Life Sciences
Top stories summarized by our editors
8/17/2018

Women in the health sciences will be fully valued and celebrated only after a culture change, said Albert and Mary Lasker Foundation President Claire Pomeroy in a keynote speech at Modern Healthcare's Women Leaders in Healthcare summit. Men should also be invited to join campaigns against sexual harassment and assault, said Christine Malcolm, executive director of the Carol Emmott Fellowship.

8/17/2018

Women whose mothers lived to 90 years old are 25% more likely to live that long themselves than women whose mothers died younger, and they are 38% more likely to live to 90 if both parents did. However, paternal longevity alone is not a factor in whether a woman would live to 90, researchers report in Age and Ageing, although genetic, lifestyle and environmental factors as well as education and income contribute to women's longevity, study leader Aladdin Shadyab says.

More Summaries:
Ageing
8/17/2018

The UK government is funding a mentoring program at the University of Birmingham in partnership with Aberystwyth University and University Hospitals Birmingham NHS Foundation Trust to identify sources of gender bias and whether women are encouraged to pursue research in particular areas outside of STEM subjects. Junior female academics from an ethnic minority will mentor senior, white, male colleagues.

8/17/2018

Physicist Jess Wade and chemist Claire Murray have launched a crowdfunding campaign to donate copies of Angela Saini's "Inferior: How Science Got Women Wrong -- and the New Research That's Rewriting the Story" to every state school in the UK, and the publisher has agreed to match donations. "We meet too many girls who, despite being brilliant, are not confident, and are unsure of their own potential to become scientists," Wade and Murray wrote in the crowdfunding request.

Full Story:
The Guardian (London)
8/17/2018

A previously announced offering of $650 million worth of 0.0% convertible senior notes due Aug. 15, 2023, has been priced by Illumina, with principal notes of $1,000 to be converted into around 2.18 common shares, which is equivalent to the $457.77 conversion price. The company intends to use net proceeds of approximately $637 million for repurchasing common stock, as well as for general corporate purposes.

Full Story:
Seeking Alpha
More Summaries:
Illumina
8/17/2018

A public offering of 1.5 million shares of common stock has been priced by Minnesota-based IntriCon at $55 each in hopes of raising around $82.5 million. The company, which will also offer a 30-day option for underwriters to buy 225,000 more shares, intends to use net proceeds of about $77.3 million for working capital, debt repayment, capital expenditures, share repurchasing and retirement, and general corporate purposes.

Full Story:
MassDevice (Boston)
More Summaries:
IntriCon
8/17/2018

A private placement of around 3.2 million shares of common stock has brought in approximately $5 million in gross proceeds for Second Sight. The money will be used to conduct a feasibility study and other data collection for the company's Orion cortical visual prosthesis system, as well as for advanced artificial vision research and further development of the Argus 2s next-generation devices.

Full Story:
MassDevice (Boston)
More Summaries:
Second Sight Medical, Orion
8/17/2018

Genetic Technologies, an Australian molecular diagnostics company, has entered a partnership with Beijing Zishan Health Consultancy to discuss a possible joint venture that would bring the company's genomic tests to China. The partners, which did not disclose additional terms of the deal, will also consider establishing a genetic testing facility in China.

More Summaries:
Genetic Technologies
8/17/2018

Dale Wolf has been tapped to serve as vice president of manufacturing at NuVasive. Wolf was most recently executive of shop operations for Florence, S.C., at GE Healthcare, where he served for two decades.

Full Story:
Becker's Spine Review
More Summaries:
GE Healthcare, NuVasive
8/17/2018

The CMS has granted Finland-based orthopedic device maker Bone Index coverage under Medicare and Medicaid for the use of its Bindex point-of-care osteoporosis measurement device in outpatient and ambulatory surgical practices. The tool measures the tibia's cortical bone thickness and calculates an estimate of bone mineral density at the hip.

More Summaries:
Medicare, Medicaid